Hiv-treatment method with low-toxicity amphotericin b

Details Hiv-treatment method with low-toxicity amphotericin b Hiv-treatment method with low-toxicity amphotericin b

A - Human Necessities

61

K

A61K 9/51 (2006.01) A61K 9/16 (2006.01) A61K 31/71 (1990.01)

Patent

CA 2113272

2113272 9303737 PCTABS00020 A method of inhibiting HIV infection in peripheral blood macrophages, as evidenced by an inhibition of HIV p24 antigen expression in the infected cells. The method includes exposing the infected macrophages to a composition containing particles of amphotericin B:cholesteryl sulfate, molar ratio 1:0.5 to 1:4, at a concentration of at least about 0.01 µM amphotericin B.

Affiliated with

Also associated with

Rating

Hiv-treatment method with low-toxicity amphotericin b does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv-treatment method with low-toxicity amphotericin b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv-treatment method with low-toxicity amphotericin b will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1876018